Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 681700 of 20,252 grants

Active OTHER RESEARCH-RELATED
FUture Surgeons and Scientists Investigating ONcology
NATIONAL CANCER INSTITUTE University of Alabama At Birmingham United States 2024 – 2029

Project Summary The FUture Surgeons and Scientists Investigating ONcology (FUSSION) YES program at the University of Alabama at Birmingham (UAB) is designed to increase interest in...

$810.7K
USD
Active NON-SBIR/STTR RPGS
Survivorship in Patients with Multiple Myeloma Treated with Chimeric Antigen Receptor T-cell Therapy
NATIONAL CANCER INSTITUTE H. Lee Moffitt Cancer Ctr & Res Inst United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT Multiple myeloma is the second most common hematologic cancer in the US and remains incurable, with virtually all patients developing relapsed or refractor...

$6.91M
USD
Active NON-SBIR/STTR RPGS
Harnessing naturally occurring cell type-specific regulatory elements and normal HSC hematopoiesis to develop cell lineage-controlled CAR expression and continuously renewing CAR NK cells
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2029

Project Summary CAR T cell therapies have been revolutionary for patients with relapsed/refractory hematologic malignancies; however, the relapse rates are unacceptably high, with...

$5.14M
USD
Active NON-SBIR/STTR RPGS
Identifying Multi-Level Predictors and Outcomes of Oral Anticancer Medication Adherence Initiation and Persistence among Patients with Hematologic Malignancies
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2024 – 2029

Oral anticancer medications (OAM) are becoming standard of care for growing numbers of patients. Multiple myeloma (MM), chronic myeloid leukemia (CML), and chronic lymphocytic leuk...

$6.57M
USD
Active NON-SBIR/STTR RPGS
Evaluation of a Proactive Identification and Digital Mental Health Intervention Approach to Address Unmet Psychosocial Needs of Individuals Living with Likely Incurable Cancer
NATIONAL CANCER INSTITUTE Medical University of South Carolina United States 2024 – 2029

ABSTRACT Individuals living with likely incurable cancer (ILLIC) are a heterogeneous, growing subpopulation of cancer survivors who have unique survivorship care needs. Principal a...

$6.22M
USD
Active NON-SBIR/STTR RPGS
Novel biologic RNA molecules to modulate HCC metabolism
NATIONAL CANCER INSTITUTE University of California At Davis United States 2024 – 2029

PROJECT SUMMARY Liver cancer is a major cause of cancer-related deaths within the United States, being the fifth and seventh leading cause of cancer deaths among men and women, res...

$4.84M
USD
Active NON-SBIR/STTR RPGS
Engage: A Randomized Controlled Trial Testing the Efficacy of a Telehealth-Delivered Psychosocial Intervention to Decrease Symptom Interference in Patients with Advanced Cancer
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2029

Pain, fatigue, and distress are highly prevalent co-occurring symptoms in patients with advanced cancer. When these symptoms interfere with patients’ daily lives, it can diminish t...

$5.78M
USD
Active NON-SBIR/STTR RPGS
Mosaic: RCT of a Digital Health Intervention Delivering Peer Support Narratives and Psychoeducation to English- and Spanish-Speaking Stem Cell Transplant Recipients
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2024 – 2029

Cancer patients undergoing hematopoietic stem cell transplant (SCT) face numerous challenges because of this treatment’s toxicity, lengthy hospitalization and recovery, and persist...

$7.17M
USD
Active NON-SBIR/STTR RPGS
The urinary microbiome and bladder toxicity after pelvic radiotherapy
NATIONAL CANCER INSTITUTE University of Rochester United States 2024 – 2026

Project Summary: Most men diagnosed with prostate cancer (PCa) are 65-years of age or older. Radiotherapy (RT) is an effective and curative treatment for early-stage PCa. However,...

$4.15M
USD
Active NON-SBIR/STTR RPGS
Impact of State Cannabis Laws on Cancer Pain Management and Outcomes: A mixed-methods study
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT More than one third of the approximately 2 million Americans diagnosed with cancer each year experience moderate to severe pain related to their disease an...

$5.78M
USD
Active NON-SBIR/STTR RPGS
Targeting angiotensin and inflammation to prevent radiotherapy-induced bladder toxicity.
NATIONAL CANCER INSTITUTE University of Rochester United States 2024 – 2029

ABSTRACT/SUMMARY Radiotherapy (RT) is an effective treatment modality for pelvic malignancies. However, radiation cystitis (RC) is a widely recognized irreversible and chronic cond...

$5.5M
USD
Active NON-SBIR/STTR RPGS
A Pragmatic Randomized Controlled Trial to Evaluate the Effectiveness of an Intervention to Promote Guideline-Concordant Colorectal Cancer Surveillance
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2029

ABSTRACT The transition from curative-intent treatment to survivorship can be an overwhelming and confusing time for patients with colorectal cancer (CRC). Surveillance for cancer...

$5.92M
USD
Active NON-SBIR/STTR RPGS
Genomic Analysis of Inherited Breast and Ovarian Cancer
NATIONAL CANCER INSTITUTE University of Washington United States 2024 – 2029

The discovery of BRCA1 and BRCA2 and other genes of homologous recombination repair, and the characterization of the roles of these genes in inherited predisposition to breast and...

$6.45M
USD
Active NON-SBIR/STTR RPGS
Harnessing Tumor and Circulating-Free DNA Methylation for Prognosis and Treatment Stratification in Adenoid Cystic Carcinoma
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2029

Abstract Adenoid Cystic Carcinoma (ACC) is a common salivary gland cancer for which there is no standard systemic therapy. ACC has a heterogeneous behavior; while most patients hav...

$3.71M
USD
Active NON-SBIR/STTR RPGS
Pilot testing of metacognitive strategy training to address cancer-related cognitive impairment in breast cancer
NATIONAL CANCER INSTITUTE University of Missouri-Columbia United States 2024 – 2026

Project Summary/Abstract The long-term goal of this research is to reduce the functional impact of cognitive impairment and improve quality-of-life in women treated for breast canc...

$4.02M
USD
Active OTHER RESEARCH-RELATED
Assess and Design a Multi-level Intervention with Middle to Older Age Mexican Immigrants to Increase Cervical Cancer Screening in Community Health Clinics
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2024 – 2029

PROJECT SUMMARY / ABSTRACT Cervical cancer is the fourth most common cancer affecting people with a cervix worldwide, after breast, colorectal, and lung cancers, with 569,847 new c...

$1.77M
USD
Active NON-SBIR/STTR RPGS
Novel chemokine in the regulation of breast cancer metastasis
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2024 – 2026

Project Summary Our long-term goal is to understand the immunobiology of cancer and identify the molecular drivers that promote the metastatic progression of cancer. We discovered...

$4.14M
USD
Active OTHER RESEARCH-RELATED
De novo designed Ras tools to uncover the mechanisms underlying drug resistance
NATIONAL CANCER INSTITUTE University of Washington United States 2024 – 2026

The Ras family of proteins contain four major isoforms, and altogether these proteins are constitutively activated in a third of cancers. In the past decade, inhibitors to mutant R...

$1.1M
USD
Active OTHER RESEARCH-RELATED
Investigating personalized approaches to de-intensify therapy for nodular lymphocyte-predominant Hodgkin lymphoma
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2029

PROJECT SUMMARY/ABSTRACT: Michael Binkley, MD, MS is an Assistant Professor of Radiation Oncology at Stanford University School of Medicine. His long-term career goal is to combine...

$2.85M
USD
Active OTHER RESEARCH-RELATED
Cell-Free DNA Methylation Patterns as a Biomarker for Tumor Biology and Clinical Outcomes for Glioblastoma Patients
NATIONAL CANCER INSTITUTE Duke University United States 2024 – 2026

ABSTRACT Glioblastoma is a uniformly lethal brain tumor despite aggressive and toxic standard of care treatments including surgery, radiation, and chemotherapy. One of the main bar...

$1.01M
USD